Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Kiora Pharmaceuticals (KPRX) Debt Ratio (2020 - 2023)

Kiora Pharmaceuticals' Debt Ratio history spans 5 years, with the latest figure at 0.03 for Q3 2023.

  • For Q3 2023, Debt Ratio rose 75.31% year-over-year to 0.03; the TTM value through Sep 2023 reached 0.03, up 75.31%, while the annual FY2020 figure was 0.02, N/A changed from the prior year.
  • Debt Ratio reached 0.03 in Q3 2023 per KPRX's latest filing, up from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.03 in Q3 2023 to a low of 0.01 in Q1 2021.
  • Average Debt Ratio over 4 years is 0.02, with a median of 0.02 recorded in 2020.
  • The largest YoY upside for Debt Ratio was 75.31% in 2023 against a maximum downside of 19.13% in 2023.
  • A 4-year view of Debt Ratio shows it stood at 0.02 in 2020, then dropped by 26.31% to 0.01 in 2021, then soared by 32.59% to 0.02 in 2022, then surged by 75.31% to 0.03 in 2023.
  • Per Business Quant, the three most recent readings for KPRX's Debt Ratio are 0.03 (Q3 2023), 0.02 (Q2 2023), and 0.02 (Q1 2023).